Ubs Asset Management Americas Inc Ocular Therapeutix, Inc Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 218,588 shares of OCUL stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
218,588
Previous 147,684
48.01%
Holding current value
$1.69 Million
Previous $1.28 Million
45.33%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding OCUL
# of Institutions
190Shares Held
132MCall Options Held
374KPut Options Held
179K-
Summer Road LLC West Palm Beach, FL13.9MShares$107 Million98.85% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.8MShares$99.1 Million4.83% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$98.5 Million17.98% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$88.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.48MShares$65.5 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $594M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...